GlaxoSmithKline Inc

Registered Principal Details

Business Or Interest:
Pharmaceutical Manufacturer.

Lobbying Interests:
Lobby areas of healthcare, wellness, and pharmaceutical issues.

CEO Name:
Emma Wamsly

Contact
SB
Sandie Benen
47 W. Division Street, #234
Chicago, IL 60610
(312) 504-4080
sandra.e.benen@gsk.com
http://www.gsk.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 773
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
1/10/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 737
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
12/6/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Issues relating to health insurance cost-sharing requirements
Development, drafting or introduction of a proposal relating to
Issues relating to health insurance cost-sharing requirements

Notification Date
1/18/2023
First Communication Date
1/18/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

Total Lobbying Effort

  2023
January - June
2023
July - December
2024
January - June
Total
Total Lobbying Expenditures 2023
January - June
$7,837.50
2023
July - December
$3,812.50
2024
January - June
$3,125.00
Total $14,775.00
Total Hours Communicating 2023
January - June
8.75
2023
July - December
5.00
2024
January - June
4.50
Total 18.25
Total Hours Other 2023
January - June
43.50
2023
July - December
25.50
2024
January - June
20.50
Total 89.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
20%
2024
January - June
10%
2024
July - December
Total 8%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
80%
2023
July - December
55%
2024
January - June
2024
July - December
Total 54%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 5%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
25%
2024
January - June
90%
2024
July - December
Total 33%

Filed Statements of Lobbying Activity and Expenditures